Cogent Biosciences Inc (NAS:COGT)
$ 8.8 0.42 (5.01%) Market Cap: 841.40 Mil Enterprise Value: 606.18 Mil PE Ratio: 0 PB Ratio: 4.21 GF Score: 30/100

Cogent Biosciences Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 01:30PM GMT
Release Date Price: $11.5 (-1.71%)
Eun Yang
(Trades, Portfolio) LLC - Analyst

Good evening, everyone. This is Eun Yang, a biotech analyst with Jefferies. I'm happy to have a fireside chat with Cogent CEO, Andy Robbins.

Andy, before we start the Q&A, could you give us a quick overview of what Cogent does?

Andy Robbins
Cogent Biosciences, Inc. - CEO & President

Sure then. Eun, thanks so much for inviting us to the conference today. Happy to be here even with a smog. So hopefully, excuse my gravelly throat today.

Before I do the intro, just to remind folks for a better and more full characterization of risks to take a look at our SEC disclosures as I probably will be making some forward-looking statements today.

So for those that aren't as familiar with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot